117 related articles for article (PubMed ID: 285298)
1. Comparative effects of cyclophosphamide, isophosphamide, 4-methylcyclophosphamide, and phosphoramide mustard on murine hematopoietic and immunocompetent cells.
Sensenbrenner LL; Marini JJ; Colvin M
J Natl Cancer Inst; 1979 Apr; 62(4):975-81. PubMed ID: 285298
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of in vivo and in vitro murine immune responses by the cyclophosphamide metabolite acrolein.
Kawabata TT; White KL
Cancer Res; 1988 Jan; 48(1):41-5. PubMed ID: 3257162
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
4. Vomiting induced by cyclophosphamide and phosphoramide mustard in cats.
Fetting JH; McCarthy LE; Borison HL; Colvin M
Cancer Treat Rep; 1982 Aug; 66(8):1625-9. PubMed ID: 7105052
[TBL] [Abstract][Full Text] [Related]
5. Effects of oxazaphosphorine cytostatics on granuloid progenitor cell (CFUc) proliferation in mice.
Semont H; Hecquet C; Adolphe M; Deysson G
Exp Hematol; 1982 Oct; 10(9):782-8. PubMed ID: 7173344
[TBL] [Abstract][Full Text] [Related]
6. [Effect of preliminary administration of allogenic cells on transplantation immunity in mice receiving cyclophosphamide].
Cherniakhovskaia IIu; Fontalin LN; Rubakova EI
Biull Eksp Biol Med; 1978 Feb; 85(2):192-4. PubMed ID: 564721
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
Phelan ET; Vietti TJ; Valeriote FA; Coulter D
Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
[TBL] [Abstract][Full Text] [Related]
8. In vitro alteration of canine renal allografts with cyclophosphamide metabolites.
Zincke H; Jardine I; Colvin M; Aydin G; Okiye SE
Transplant Proc; 1983 Jun; 15(2):1698-701. PubMed ID: 6349051
[TBL] [Abstract][Full Text] [Related]
9. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
Spielmann H; Jacob-Müller U
Teratology; 1981 Feb; 23(1):7-13. PubMed ID: 7245091
[TBL] [Abstract][Full Text] [Related]
10. Effect of fractional cyclophosphamide dosage on sheep red blood cell-delayed-type hypersensitivity response in mice.
Rondinone SN; Giovanniello OA; Barrios HA; Nota NR
J Immunol; 1983 Apr; 130(4):1600-3. PubMed ID: 6220061
[TBL] [Abstract][Full Text] [Related]
11. Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines.
Kohn FR; Landkamer GJ; Manthey CL; Ramsay NK; Sladek NE
Cancer Res; 1987 Jun; 47(12):3180-5. PubMed ID: 3034402
[TBL] [Abstract][Full Text] [Related]
12. Cross-linking of DNA in L1210 cells and nuclei treated with cyclophosphamide and phosphoramide mustard.
Surya YA; Rosenfeld JM; Hillcoat BL
Cancer Treat Rep; 1978 Jan; 62(1):23-9. PubMed ID: 564237
[TBL] [Abstract][Full Text] [Related]
13. Immune mechanisms in leukemia: suppression of cellular immunity by drugs and x-irradiation.
Martinez D; Lukasewycz OA; Murphy WH
J Immunol; 1975 Sep; 115(3):724-9. PubMed ID: 1151076
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation.
Sladek NE; Doeden D; Powers JF; Krivit W
Cancer Treat Rep; 1984 Oct; 68(10):1247-54. PubMed ID: 6395951
[TBL] [Abstract][Full Text] [Related]
15. The influence of cyclophosphamide on antibody formation in the mouse.
Willers JM; Sluis E
Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide.
Struck RF; Schmid SM; Waud WR
Cancer Chemother Pharmacol; 1994; 34(3):191-6. PubMed ID: 8004750
[TBL] [Abstract][Full Text] [Related]
17. Effect of three alkylating antimitotic agents and their metabolites on in vitro monogranulocytic colony forming cells from mouse bone marrow.
Semont H; Hecquet C; Adolphe M; Deysson G
Arzneimittelforschung; 1981; 31(3):470-3. PubMed ID: 7194671
[TBL] [Abstract][Full Text] [Related]
18. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
Hales BF
Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
[TBL] [Abstract][Full Text] [Related]
19. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
Naito K; Pellis NR; Kahan BD
Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
[TBL] [Abstract][Full Text] [Related]
20. Effects of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of murine late spleen colony-forming cells (day-12 CFU-S) and hematopoietic repopulating cells to mafosfamide (ASTA Z 7557).
Kohn FR; Sladek NE
Biochem Pharmacol; 1987 Sep; 36(17):2805-11. PubMed ID: 2820422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
